Acquisition by Young Caroline of tradable shares of Cumberland Pharmaceuticals at 1.48 subject to Rule 16b-3
| CPIX Stock | USD 2.27 0.05 2.16% |
Slightly above 56% of all Cumberland Pharmaceuticals' investors are looking to take a long position. The analysis of overall sentiment of trading Cumberland Pharmaceuticals stock suggests that some investors are interested at this time. Cumberland Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Cumberland Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Cumberland |
Filed transaction by Cumberland Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Cumberland Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cumberland Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Cumberland Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cumberland Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cumberland Pharmaceuticals Fundamental Analysis
We analyze Cumberland Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cumberland Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cumberland Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Cumberland Pharmaceuticals is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Cumberland Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cumberland Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cumberland Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cumberland Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Cumberland Pharmaceuticals Related Equities
| IRWD | Ironwood Pharmaceuticals | 14.69 | ||||
| CPHI | China Pharma | 8.75 | ||||
| AKAN | Akanda Corp | 3.68 | ||||
| PROC | Procaps Group | 2.87 | ||||
| LFCR | Lifecore Biomedical | 2.40 | ||||
| KMDA | Kamada | 1.72 | ||||
| ORGO | Organogenesis Holdings | 1.93 | ||||
| BFRI | Biofrontera | 4.07 | ||||
| PTPI | Petros Pharmaceuticals | 5.16 | ||||
| SHPH | Shuttle Pharmaceuticals | 5.88 | ||||
| RGC | Regencell Bioscience | 5.93 | ||||
| IXHL | Incannex Healthcare | 6.15 | ||||
| EVOK | Evoke Pharma | 7.65 | ||||
| PRFX | Painreform | 52.51 |
Additional Tools for Cumberland Stock Analysis
When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.